BG51341A3 - Method for the preparation of pharmaceutical mixture - Google Patents

Method for the preparation of pharmaceutical mixture

Info

Publication number
BG51341A3
BG51341A3 BG61387A BG6138783A BG51341A3 BG 51341 A3 BG51341 A3 BG 51341A3 BG 61387 A BG61387 A BG 61387A BG 6138783 A BG6138783 A BG 6138783A BG 51341 A3 BG51341 A3 BG 51341A3
Authority
BG
Bulgaria
Prior art keywords
preparation
pharmaceutical mixture
pharmaceutical
mixture
Prior art date
Application number
BG61387A
Other languages
English (en)
Inventor
Anders G Kaellstrand
Kjell J Mattsson
Rolf I Sjoeqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of BG51341A3 publication Critical patent/BG51341A3/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG61387A 1982-06-24 1983-06-20 Method for the preparation of pharmaceutical mixture BG51341A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture

Publications (1)

Publication Number Publication Date
BG51341A3 true BG51341A3 (en) 1993-04-15

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
BG61387A BG51341A3 (en) 1982-06-24 1983-06-20 Method for the preparation of pharmaceutical mixture

Country Status (29)

Country Link
EP (1) EP0101418B1 (ru)
JP (1) JPS5916822A (ru)
KR (1) KR910000028B1 (ru)
AR (1) AR231075A1 (ru)
AT (1) ATE59286T1 (ru)
AU (1) AU561954B2 (ru)
BG (1) BG51341A3 (ru)
CA (1) CA1214726A (ru)
CS (1) CS257769B2 (ru)
CY (1) CY1468A (ru)
DD (1) DD209971A5 (ru)
DE (1) DE3382086D1 (ru)
DK (1) DK161365C (ru)
ES (1) ES523536A0 (ru)
FI (1) FI85213C (ru)
GB (1) GB2122490B (ru)
GR (1) GR78604B (ru)
HK (1) HK98786A (ru)
HU (1) HU189300B (ru)
IE (1) IE55204B1 (ru)
IS (1) IS1325B6 (ru)
MY (1) MY8700292A (ru)
NO (1) NO168745C (ru)
NZ (1) NZ204639A (ru)
PH (1) PH21911A (ru)
PT (1) PT76919B (ru)
SE (1) SE8203953D0 (ru)
SU (1) SU1722207A3 (ru)
ZA (1) ZA833931B (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
WO1989010117A1 (en) * 1988-04-19 1989-11-02 Southwest Research Institute Controlled release of active ingredients from capsules having a salt sensitive shell material
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
ATE352289T1 (de) * 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (ru) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
ES434971A1 (es) * 1974-02-22 1977-05-16 Wellcome Found Metodo para producir un preparado farmaceutico que comprendeuna solucin de digoxina en una envolvente de capsula solu- ble.
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
AR231075A1 (es) 1984-09-28
DK161365B (da) 1991-07-01
IE831462L (en) 1983-12-24
NO832293L (no) 1983-12-27
FI832197A0 (fi) 1983-06-16
ES8403720A1 (es) 1984-04-01
PT76919A (en) 1983-07-01
HU189300B (en) 1986-06-30
KR840005024A (ko) 1984-11-03
DD209971A5 (de) 1984-05-30
ZA833931B (en) 1984-07-25
HK98786A (en) 1986-12-24
DK272383D0 (da) 1983-06-14
NO168745B (no) 1991-12-23
GB8317071D0 (en) 1983-07-27
CS463683A2 (en) 1987-11-12
SE8203953D0 (sv) 1982-06-24
EP0101418A3 (en) 1984-11-14
FI85213B (fi) 1991-12-13
GR78604B (ru) 1984-09-27
JPH0559089B2 (ru) 1993-08-30
IE55204B1 (en) 1990-07-04
EP0101418A2 (en) 1984-02-22
GB2122490B (en) 1986-04-03
AU561954B2 (en) 1987-05-21
PT76919B (en) 1986-04-09
DK161365C (da) 1991-12-09
NZ204639A (en) 1986-01-24
CA1214726A (en) 1986-12-02
EP0101418B1 (en) 1990-12-27
DK272383A (da) 1983-12-25
MY8700292A (en) 1987-12-31
FI85213C (fi) 1992-03-25
CY1468A (en) 1989-07-21
AU1594383A (en) 1984-01-05
PH21911A (en) 1988-04-08
FI832197L (fi) 1983-12-25
GB2122490A (en) 1984-01-18
JPS5916822A (ja) 1984-01-28
ES523536A0 (es) 1984-04-01
IS2824A7 (is) 1983-12-25
ATE59286T1 (de) 1991-01-15
CS257769B2 (en) 1988-06-15
KR910000028B1 (ko) 1991-01-19
DE3382086D1 (de) 1991-02-07
IS1325B6 (is) 1988-08-03
SU1722207A3 (ru) 1992-03-23
NO168745C (no) 1992-04-01

Similar Documents

Publication Publication Date Title
PT76830A (en) Process for the preparation of 1h-indole-methanesulphonamides
BG51341A3 (en) Method for the preparation of pharmaceutical mixture
DE3368047D1 (en) Process for the preparation of p-nitrosodiphenylamine
CY1470A (en) Process for the preparation of phenylalkylaminoethylsalicylamide
DE3377061D1 (en) Process for the preparation of 1-sulfo-2-oxoazetidine derivatives
EG16223A (en) Process for the preparation of novel pharmaceutical compounds
ZA836193B (en) Process for the preparation of n-allyl-o-alkyl thioncarbamates
DE3361137D1 (en) Method for the preparation of 3-alkoxy-acrylonitriles
PT76175A (en) Process for the preparation of benzothienyl-dialkylallylamines
PT76598A (en) Process for the preparation of pleuromutyline derivatives
DE3372479D1 (en) Process for the preparation of 4-chloro-2-nitrobenzonitrile
DE3362429D1 (en) Process for the preparation of thiadiazoloxyacetamides
DE3367912D1 (en) Process for the preparation of n-allyl-o-alkyl-thioncarbamates
DE3360384D1 (en) Process for the preparation of 1-hydroxyketones
DE3361356D1 (en) Process for the preparation of 3-acylaminoanilines
DE3364900D1 (en) Process for the preparation of encapsulable globules
DE3365382D1 (en) Process for the preparation of 2-chlorobenzoxazols
ZM8083A1 (en) Process for the preparation of opticaly
PT76229A (en) Process for the preparation of a pharmaceutical composition containing oxazolidin-2-ones
ZA837066B (en) Process for the preparation of n-acetyl-p-aminophenol
GB2120245B (en) Process for the preparation of 3-hydroxy-benzo-diazepinones
DE3369844D1 (en) Process for the preparation of 2-imidazolines
DE3365483D1 (en) Process for the preparation of 2-alkylthiomethyl-4-hydroxy-pyrimidines
DE3361771D1 (en) Method for the preparation of pure 2-chloro-6-alkoxy-3-nitro-pyridines
IL69304A0 (en) Method for the preparation of difluoromethoxyaromatic compounds